Author’s Accepted Manuscript New insight into NANOG: A novel therapeutic target for ovarian cancer (OC) Iyer Mahalaxmi, Subramaniam Mohana Devi, Jayaramayya Kaavya, Swaminathan Arul, Vellingiri Balachandar, Kumaran Sivanandan Santhy PII: S0014-2999(19)30152-9 DOI: https://doi.org/10.1016/j.ejphar.2019.03.003 Reference: EJP72261 To appear in: European Journal of Pharmacology Received date: 15 November 2018 Revised date: 20 February 2019 Accepted date: 1 March 2019 Cite this article as: Iyer Mahalaxmi, Subramaniam Mohana Devi, Jayaramayya Kaavya, Swaminathan Arul, Vellingiri Balachandar and Kumaran Sivanandan Santhy, New insight into NANOG: A novel therapeutic target for ovarian cancer ( O C ) , European Journal of Pharmacology, https://doi.org/10.1016/j.ejphar.2019.03.003 This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting galley proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain. www.elsevier.com/locate/ejphar